Chintagumpala, Murali <br/><br/>
A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.  [electronic resource] 

 -  Neuro-oncology  Feb 2009 
 - 33-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-8517 
<br/><br/><label>Standard No.: </label>10.1215/15228517-2008-079  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Child<br/>Child, Preschool<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Cranial Irradiation<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Dose-Response Relationship, Radiation<br/>Female<br/>Gamma Rays<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Male<br/>Neuroectodermal Tumors, Primitive--drug therapy<br/>Pilot Projects<br/>Risk Factors<br/>Supratentorial Neoplasms--drug therapy<br/>Survival Rate<br/>Treatment Outcome<br/>Vincristine--administration & dosage